Your Health Plan:
Your Health Plan:
Not SelectedUPTRAVI (selexipag) is a brand-name prescription drug for treatment of Idiopathic pulmonary arterial hypertension. UPTRAVI is a prostacyclin receptor agonist. It is available in the form of oral tablet / intravenous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $300-41100.
Patient Assistance Prorgams and Coupons are found:
Other alternatives to UPTRAVI may include:
